These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. COVID 19 convalescent plasma: Is there still a place for CCP? Moog R Transfus Apher Sci; 2023 Apr; 62(2):103680. PubMed ID: 36870907 [TBL] [Abstract][Full Text] [Related]
15. COVID-19 convalescent plasma treatment of moderate and severe cases of SARS-CoV-2 infection: A multicenter interventional study. Alsharidah S; Ayed M; Ameen RM; Alhuraish F; Rouheldeen NA; Alshammari FR; Embaireeg A; Almelahi M; Adel M; Dawoud ME; Aljasmi MA; Alshammari N; Alsaeedi A; Al-Adsani W; Arian H; Awad H; Alenezi HA; Alzafiri A; Gouda EF; Almehanna M; Alqahtani S; Alshammari A; Askar MZ Int J Infect Dis; 2021 Feb; 103():439-446. PubMed ID: 33285283 [TBL] [Abstract][Full Text] [Related]
16. Treatment of COVID-19 Patients with Two Units of Convalescent Plasma in a Resource-Constrained State. Ipe TS; Ugwumba B; Spencer HJ; Le T; Ridenour T; Armitage J; Ryan S; Pearson S; Kothari A; Patil N; Dare R; Crescencio JCR; Venkata A; Laudadio J; Mohammad K; Jamal N; Thompson J; McNew H; Gibbs M; Hennigan S; Kellar S; Reitzel K; Walser BE; Novak A; Quinn B Lab Med; 2022 Nov; 53(6):623-628. PubMed ID: 35771890 [TBL] [Abstract][Full Text] [Related]
17. Nucleocapsid-specific antibody function is associated with therapeutic benefits from COVID-19 convalescent plasma therapy. Herman JD; Wang C; Burke JS; Zur Y; Compere H; Kang J; Macvicar R; Taylor S; Shin S; Frank I; Siegel D; Tebas P; Choi GH; Shaw PA; Yoon H; Pirofski LA; Julg BD; Bar KJ; Lauffenburger D; Alter G Cell Rep Med; 2022 Nov; 3(11):100811. PubMed ID: 36351430 [TBL] [Abstract][Full Text] [Related]
18. Endemic Human Coronavirus Antibody Levels Are Unchanged after Convalescent or Control Plasma Transfusion for Early Outpatient COVID-19 Treatment. Karaba AH; Johnston TS; Beck E; Laeyendecker O; Cox AL; Klein SL; Sullivan DJ; mBio; 2023 Feb; 14(1):e0328722. PubMed ID: 36625657 [TBL] [Abstract][Full Text] [Related]
19. Blood Endothelial-Cell Extracellular Vesicles as Potential Biomarkers for the Selection of Plasma in COVID-19 Convalescent Plasma Therapy. Amri N; Tessier N; Bégin R; Vachon L; Bégin P; Bazin R; Loubaki L; Martel C Cells; 2022 Oct; 11(19):. PubMed ID: 36231083 [TBL] [Abstract][Full Text] [Related]
20. Treatment of COVID-19 with convalescent plasma in patients with humoral immunodeficiency - Three consecutive cases and review of the literature. Delgado-Fernández M; García-Gemar GM; Fuentes-López A; Muñoz-Pérez MI; Oyonarte-Gómez S; Ruíz-García I; Martín-Carmona J; Sanz-Cánovas J; Castaño-Carracedo MÁ; Reguera-Iglesias JM; Ruíz-Mesa JD Enferm Infecc Microbiol Clin (Engl Ed); 2022 Nov; 40(9):507-516. PubMed ID: 36336380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]